These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 5017540)

  • 41. [Comparative effect of erychroside and strophanthin on the intensity of coronary blood flow].
    Liubetskaia ZhA; Bezruk PI; Angarskaia MA
    Farmakol Toksikol; 1966; 29(2):180-3. PubMed ID: 6000341
    [No Abstract]   [Full Text] [Related]  

  • 42. [Pharmacology and therapeutic effects of a new semisynthetic cardioactive glycoside (P1)].
    Königstein RP; Lindner A; Selzer H
    Wien Med Wochenschr; 1971 Jan; 121(4):53-6. PubMed ID: 5103273
    [No Abstract]   [Full Text] [Related]  

  • 43. [Clinical experience with the purified glycoside convallatoxin].
    WEISE H; ESSER H
    Med Klin; 1956 Mar; 51(11):432-3. PubMed ID: 13308774
    [No Abstract]   [Full Text] [Related]  

  • 44. [Organic analysis. XLII. Colorimetric determination of cardiac glycosides with trintrobenzene].
    MOMOSE T; MATSUKUMA T; OHKURA Y; NAKAMURA Y
    Yakugaku Zasshi; 1963 Feb; 83():143-7. PubMed ID: 13935964
    [No Abstract]   [Full Text] [Related]  

  • 45. The effects of six cardiac glycosides on the transmembrane potential and contractile characteristics of the right ventricle of guinea pigs.
    Ito M; Hollander PB; Marks BH; Dutta S
    J Pharmacol Exp Ther; 1970 Mar; 172(1):188-95. PubMed ID: 5416942
    [No Abstract]   [Full Text] [Related]  

  • 46. Treatment of chronic right-heart lesions. Proscillaridin for cor pulmonale and the senile heart.
    Neumann H
    Geriatrics; 1966 Jun; 21(6):180-5. PubMed ID: 5949184
    [No Abstract]   [Full Text] [Related]  

  • 47. [Treatment of heart failure, with special consideration of iatrogenic complications].
    Lüderitz B; Avenhaus H
    Munch Med Wochenschr; 1970 Oct; 112(40):1779-84. PubMed ID: 5536213
    [No Abstract]   [Full Text] [Related]  

  • 48. [Binding of cardiac glycosides and of similarly acting bisguanyl hydrazones to ribonucleic acid].
    Riechert M
    Arzneimittelforschung; 1973 Apr; 23(4):549-53. PubMed ID: 4575954
    [No Abstract]   [Full Text] [Related]  

  • 49. [Directed glycoside therapy of manifest heart insufficiency].
    Storz H
    Med Klin; 1971 Apr; 66(16):587-92. PubMed ID: 5552925
    [No Abstract]   [Full Text] [Related]  

  • 50. [Recent acquisitions in the study of the pharmacology of cardiac glycosides. Pharmacokinetic approach to therapy with cardiac glycosides].
    Lesne M
    J Pharm Belg; 1973; 28(2):217-33. PubMed ID: 4733470
    [No Abstract]   [Full Text] [Related]  

  • 51. [Comparative study of the resorption, distribution, and excretion of digitalis glycosides in experimental animals].
    Buchtela K; Drexler K; Fehringer A; Hackl H; Königstein M; Schläger J
    Wien Z Inn Med; 1970; 51(5):227-35. PubMed ID: 5535605
    [No Abstract]   [Full Text] [Related]  

  • 52. [Principles of pharmacotherapy with cardiac glycosides].
    Kukes VG; Volkov RIu
    Revmatologiia (Mosk); 1983; (2):65-9. PubMed ID: 6353520
    [No Abstract]   [Full Text] [Related]  

  • 53. [The effect of some glycosides on hemodynamics in acute cardiovascular insufficiency].
    Kit SM
    Vrach Delo; 1966 Aug; 8():19-21. PubMed ID: 5989153
    [No Abstract]   [Full Text] [Related]  

  • 54. [On the combined use of adonis vernalis with cardiac glycosides and strophanthin derivatives in treating patients with circulatory insufficiency].
    Gubergrits AIa; Leshchinskiĭ LA
    Sov Med; 1968 Jan; 31(1):23-7. PubMed ID: 5691025
    [No Abstract]   [Full Text] [Related]  

  • 55. Cardiac glycosides in cancer research and cancer therapy.
    Winnicka K; Bielawski K; Bielawska A
    Acta Pol Pharm; 2006; 63(2):109-15. PubMed ID: 17514873
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [ON A SIDE-EFFECT OF CARDIAC GLYCOSIDES ON THE VISCOSITY OF THE BLOOD].
    MUELLER HE
    Blut; 1964 Mar; 10():56-60. PubMed ID: 14184691
    [No Abstract]   [Full Text] [Related]  

  • 57. [Current status of the treatment with cardiac glycosides].
    Pomerantsev VP; Kopsalova SM
    Sov Med; 1985; (7):44-8. PubMed ID: 4071234
    [No Abstract]   [Full Text] [Related]  

  • 58. [Comparison of medium-range cardiac glycosides].
    Assmann I; Fiehring H; Schmidt H; Hesse P; Banse P
    Dtsch Gesundheitsw; 1971 Dec; 26(50):2355-7. PubMed ID: 5145434
    [No Abstract]   [Full Text] [Related]  

  • 59. [Indications and contraindications for therapy with cardiac glycosides].
    Haasis R
    Fortschr Med; 1982 Aug; 100(31-32):1436-9. PubMed ID: 7129303
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Comparison of the subcellular distribution of 3H-strophanthin and 3H-digitoxin in guinea pig hearts].
    Fricke U; Gerber HG; Klaus W; Wollert U
    Naunyn Schmiedebergs Arch Exp Pathol Pharmakol; 1969; 263(1):266-7. PubMed ID: 5804287
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.